CD163 and neoplasm: Within the different tumor areas, we observed a significant lower count of CD45+ leucocytes when compared to CD68+ macrophages in all three examined areas and a significantly lower count of CD45+ leucocytes compared to CD163+ M2 type macrophages (Fig. 2A/C).